Biosceptre
Brad has been COD of Biosceptre since 2020, having joined Biosceptre as a Senior Manager (Legal and Compliance) in May 2013. With over 10 years of experience in legal and compliance management, and hands-on experience in oncology clinical study management, Brad brings the understanding and attention to detail necessary to drive clinical study outcomes through the complex operational and regulatory framework. Brad holds a Master of Business Law from the University of Sydney, a Bachelor of Business Administration from Macquarie University, and a Diploma in Law from the Legal Profession Admission Board.
This person is not in any offices
Biosceptre
Biosceptre has identified a cancer target, nf-P2X7, present in many cancer types, and importantly not found in healthy tissue.